MetLife is projected to report Q2 2026 revenue of $19.22 billion alongside a consensus EPS of $2.30, with the stock currently trading near $84.20 against an average analyst price target of $92.00. Investors are primarily focused on Variable Investment Income (VII) trends, as this volatile component has historically caused significant swings in bottom-line results.
Management's commentary on the Group Benefits segment will also be critical, specifically regarding premium growth and loss ratios amid changing labor market dynamics. Analysts will further scrutinize the impact of current interest rate levels on net investment income and the progress of the company's aggressive capital return program through share repurchases.